Overview

NCI Definition [1]:
A preparation of autologous human peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding for a T-cell chimeric antigen receptor (CAR) gene specific for the human cluster of differentiation 70 (CD70), with potential immunostimulatory and antineoplastic activities. Autologous PBLs from a patient with CD70-positive cancer are transduced with a retroviral vector that encodes the CAR gene specific for CD70. After expansion in culture and reintroduction into the patient, anti-hCD70-CAR retroviral vector-transduced autologous PBLs bind to the CD70 antigen on tumor cell surfaces; subsequently, CD70-expressing tumor cells are lysed. CD70, the ligand for the costimulatory receptor CD27, is overexpressed on the surfaces of various cancer cell types.

Anti-hcd70 car t cells has been investigated in 1 clinical trial, of which 0 are open and 1 is closed. Of the trial investigating anti-hcd70 car t cells, 1 is phase 1/phase 2 (0 open).

CD70 Expression is the most frequent biomarker inclusion criterion for anti-hcd70 car t cells clinical trials.

Malignant solid tumor is the most common disease being investigated in anti-hcd70 car t cells clinical trials [2].

Top Biomarker Inclusion Criteria for Closed Clinical Trials Investigating Anti-Hcd70 Car T Cells
This graph displays the 20 most frequently occurring biomarkers curated on clinical trials investigating anti-hcd70 car t cells and the cancer types associated with these biomarkers. These numbers are derived from a set of 5,956 clinical trials for which biomarker status defines treatment.

Drug Details

Synonyms [2]:
anti-hcd70-car retroviral vector-transduced autologous pbls, anti-hcd70 car autologous pbls, anti-hcd70 autologous car-transduced t cells, anti-hcd70-car retroviral vector-transduced autologous peripheral blood lymphocytes
NCIT ID [1]:
C129593

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.